Evaluation of chitosan nanoformulations as potent anti-HIV therapeutic systems

Biochimica et Biophysica Acta - General Subjects

Volumn 1840, Issue 1, 2014, Pages 476-484

  Ramana, Lakshmi Narashimhan ^a   Sharma, Shilpee ^b   Sethuraman, Swaminathan ^a   Ranga, Udaykumar ^b   Krishnan, Uma Maheswari ^a  

^a SASTRA UNIVERSITY   (India)

^b JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH   (India)

Author keywords

Antiretroviral; Chitosan; Nanocarrier; Saquinavir

Indexed keywords

CHITOSAN; NANOCARRIER; SAQUINAVIR;

ARTICLE; CELL PROLIFERATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENCAPSULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PARTICLE SIZE; PH; PRIORITY JOURNAL; TARGET CELL; THERMAL ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY; VIRUS INFECTION; VIRUS STRAIN; ZETA POTENTIAL;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTIRETROVIRAL; CHITOSAN; NANOCARRIER; SAQUINAVIR;

CALORIMETRY, DIFFERENTIAL SCANNING; CHITOSAN; DRUG CARRIERS; HEK293 CELLS; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; JURKAT CELLS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PARTICLE SIZE; PHAGOCYTOSIS; SAQUINAVIR;

EID: 84885963531     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2013.10.002     Document Type: Article

References (40)

1. P. Piot, M. Bartos, P.D. Ghys, N. Walker, and S. Bernhard The global impact of HIV/AIDS Nature 410 2001 968 973 (Pubitemid 32335847)
2. J.D. Neves Nanotechnology-based system for the treatment and prevention of HIV/AIDS Adv. Drug Deliv. Rev. 62 2010 458 477
3. H.L. Wong Nanotechnology application for improved delivery of antiretroviral drugs to the brain Adv. Drug Deliv. Rev. 62 2010 503 517
4. U. Gupta, and N.K. Jain Non-polymeric nano-carriers in HIV/AIDS drug delivering and targeting Adv. Drug Deliv. Rev. 62 2010 478 490
5. J.T. Radonna, S.E.C. Yie, H.Y. Fay, and E.V. Susan Mutagenesis of protease cleavage sites in the HIV type 1 gagpolyprotein J. Virol. 65 1991 922 930
6. D.K. Jardine Effect of protease inhibitors on HIV-1 maturation and infectivity Antiviral Res. 45 2000 59 68 (Pubitemid 30074193)
7. X. Li, and W.K. Chan Transport, metabolism and elimination mechanism of anti-HIV agents Adv. Drug Deliv. Rev. 39 1999 81 103 (Pubitemid 29430231)
8. E.K. Annice Saquinavir, an HIV protease inhibitor, is transported by P-glycoprotein J. Pharmacol. Exp. Ther. 286 1998 1439 1445
9. B.K. Richard The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors J. Clin. Invest. 101 1998 289 294
10. K.E. Thummel Enzyme-catalyzed process of first hepatic and intestinal drug extraction Adv. Drug Deliv. Rev. 27 1997 99 127 (Pubitemid 27417869)
11. + T-cell counts in HIV infected patients Ann. Intern. Med. 124 1996 1039 1050
12. T. Dutta, and K.J. Narendra Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer Biochim. Biophys. Acta 1770 2007 681 686 (Pubitemid 46281473)
13. E. Pretzer Inhibition of HIV-1 infection of macrophage and H9 cells by free or liposome encapsulated L-689,502, an inhibitor of the viral protease Antiviral Res. 26 1995 A358
14. L. Yang Synthesis, nanosizing and in vitro drug release of a novel anti-HIV polymeric prodrug: chitosan-O-isopropyl-5′-O-d4T monophosphate conjugate Bioorg. Med. Chem. 18 2010 117 123
15. Y.C. Kuo Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles Int. J. Pharm. 1-2 2009 206 213
16. L.K. Shah Intracellular delivery of saquinavir in biodegradable polymeric nanoparticles for HIV/AIDS Pharm. Res. 23 2006 2638 2645 (Pubitemid 44691610)
17. G. XU Bioconjugated quantum rods as targeted probes for efficient transmigration across an in vitro blood-brain barrier Bioconjug. Chem. 19 2008 1179 1185 (Pubitemid 351877059)
18. T.K. Vyas Improved oral bioavailability and brain transport of saquinavir upon administration in novel nanoemulsion formulations Int. J. Pharm. 347 2008 93 101 (Pubitemid 350180312)
19. H. Boudad Combined hydroxylpropyl-β-cyclodextrin and poly(alkyl cyanoacrylate) intended for oral administration of saquinavir Int. J. Pharm. 218 2001 113 124 (Pubitemid 32406162)
20. P. Sharma Novel drug delivery approaches on antiviral and antiretroviral agents J. Adv. Pharm. Technol. Res. 3 2012 147 159
21. L.N. Ramana Investigation on the stability of saquinavir loaded liposomes: implication on stealth, release characteristics and cytotoxicity Int. J. Pharm. 431 2012 120 129
22. Y. Yang Porcine interleukin-2 gene encapsulated in chitosan nanoparticles enhances immune response of mice to piglet paratyphoid vaccine Comp. Immunol. Microbiol. Infect. Dis. 30 2007 19 32 (Pubitemid 44913628)
23. B. Johan, and T. Pentii Blood protein adsorption onto chitosan Biomaterials 23 2002 2561 2568
24. H.P. Jae Targeted delivery of low molecular drugs using chitosan and its derivatives Adv. Drug Deliv. Rev. 62 2010 28 41
25. S. Gunaseelan Synthesis of PEG-based saquinavir prodrug conjugates and assessment of release and Anti-HIV-1 bioactivity using a novel protease inhibition assay Bioconjug. Chem. 15 2004 1322 1333 (Pubitemid 39552022)
26. R. Merlin, S. Pulavendran, C. Rose, and A.B. Mandal Chitosan nanoparticles as dual growth factor delivery system for tissue engineering applications Int. J. Pharm. 410 2011 145 152
27. H. Meringo, A. Zou, Y. Chengli, Z. Yong, Z. Jianping, W. Jing, Z. Qinny, L. Jing, and Z. Qiang Somatostatin receptor-mediated tumor-targeting drug delivery using octreotide-PEG-deoxycholic acid conjugate-modified N-deoxycholic acid-O, N-hydroxyethylation chitosan micelles Biomaterials 33 2012 6393 6407
28. K. Lalita, and Y. Rangrong Preparation, characterization and in vitro release study of carvacrol loaded chitosan nanoparticles Colloids Surf. B 84 2011 163 171
29. V. Jain Preparation and performance evaluation of saquinavir laden cationic submicron emulsions Drug Deliv. 16 2009 37 44
30. R.S. Mohammad, M.T. Roya, M. Abel, and A.R. Mohammad Synthesis and characterization of biodegradable chitosan beads as nano-carriers for local delivery of satranidazole Carbohydr. Polym. 81 2010 726 731
31. A. Jain Design and development of ligand-appended polysaccharidic nanoparticles for the delivery of oxaliplatin in colorectal cancer Nanomed. Nanotechnol. 6 2010 179 190
32. J. Liu Novel pH-sensitive chitosan-derived micelles loaded with paclitaxel Carbohydr. Polym. 82 2010 432 439
33. L.T. Min The storage stability of chitosan/tripolyphosphate nanoparticles in a phosphate buffer Carbohydr. Polym. 84 2011 756 761
34. Q. Yuvan Controlled and extended drug release behavior of chitosan based nanoparticle carrier Acta Biomater. 6 2010 1140 1148
35. Mourya Trimethyl chitosan and its applications in drug delivery J. Mater. Sci. 20 2009 1057 1079
36. Y.C. Kuo, and C.C. Wang Cationic solid lipid nanoparticles with primary and quaternary amines for release of saquinavir and biocompatibility with endothelia Colloids Surf. B 101 2013 101 105
37. A. Anitha Preparation, charaterisation, in vitro drug release and biological studies of curcumin loaded dextran sulphate-chitosan nanoparticles Carbohydr. Polym. 84 2011 1158 1164
38. G. Li Induction of Th1-type immune response by chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen Der p 2 for oral vaccination in mice Cell. Mol. Immunol. 6 2009 45 50
39. X. Li Interaction of bovine serum albumin with self assembled nanoparticles of modified chitosan 6-O-cholesterol Colloids Surf. B 92 2012 136 141
40. V.T. Marchesi Chemical characterization and surface orientation of the major glycoprotein of the human erythrocyte membrane Proc. Natl. Acad. Sci. U. S. A. 69 1972 1445 1449